Saturday, 10 October 2026 · For doctors treating diabetes and obesity
Drug page
Tirzepatide
Tirzepatide is a once-weekly injectable agonist at GIP and GLP-1 receptors. This page gathers every Diabesity Rounds report that discusses it, newest first.
Reports
Reports will appear here as new research is published.
Page updated 10 October 2026.
Today's Rounds, in your inbox at 8am
The day's reports each morning, and Weekend Rounds on Saturday. Free, no advertising.